Today's corporate reports presented a mixed financial landscape, with Celtic PLC reporting a significant revenue and profit reduction for H1 2025, primarily due to fewer home fixtures. Fundraising efforts were prominent, as Triple Point Venture VCT expanded its offer to £30 million due to strong demand, and Genedrive PLC completed a placing to secure £3.5 million for commercialization. Concurrently, Ceiba Investments is seeking bondholder approval to amend its convertible bond to avert a potential default, while WPP PLC noted Hotchkis & Wiley Capital Management crossing a 5% major holding threshold. Lloyds Banking Group also filed its comprehensive 2025 Form 20-F.
Celtic CCP, the football club, published its interim report for the six months to 31 December 2025, revealing a 28.9% decline in revenue to £59.4 million from £83.5 million in the prior period. Trading profit before intangible asset transactions fell sharply to £4.2 million, down from £26.9 million previously. The decrease was attributed to fewer home fixtures in the reporting period compared to the previous year, despite the club's participation in the UEFA Europa League Group Stages.
Hotchkis & Wiley Capital Management, a US-based investment firm, has disclosed a major holding in WPP WPP, the multinational advertising and public relations company. The notification indicates that the firm crossed the 5% voting rights threshold, now holding 5.04% of WPP's total voting rights as of February 11, 2026. This significant stake by an institutional investor could draw increased market attention to WPP's future performance and strategic direction.
Ceiba Investments CBA, an investor focused solely on Cuba, is circulating a proposal to bondholders for a second amendment to its €25 million senior, unsecured convertible bonds due 2029. This critical measure aims to secure approval to amend the original bond instrument, thereby avoiding a potential event of default. The company previously undertook a first amendment in January 2025, signaling ongoing financial pressures and a need for further restructuring.
Triple Point Venture VCT TPV has resolved to utilize the remaining £10 million of its over-allotment facility, increasing the total potential fundraising under its current offer for subscription to £30 million. This move demonstrates robust investor appetite for the Venture Capital Trust's strategy and will provide additional capital to deploy into a portfolio of qualifying growth-oriented businesses. The company's prospectus, detailing the offer, is publicly available.
Genedrive GDR, the point of care pharmacogenetic testing company, has announced the completion of its placing and a proposed direct subscription to raise up to £3.5 million. This fundraising, combined with an upcoming Open Offer, aims to secure vital capital. The funds are earmarked to support the company's operations and commercialization efforts for its innovative diagnostic products, including its FDA-approved kidneyintelX.dkd test.
Lloyds Banking Group LLOY announced it has filed its Annual Report on Form 20-F for the year ended 31 December 2025 with the Securities and Exchange Commission. This comprehensive document offers an audited overview of the bank's financial performance, strategic developments, and regulatory compliance. The report is crucial for investors seeking a detailed understanding of the group's health and outlook within the banking sector, particularly given its systemic importance in the UK.